GSK has begun the sale of some of its consumer health brands, hoping to raise around £1 billion before spinning off its consumer healthcare business, according to reports.

GlaxoSmithKline's consumer health business will be named ... The name of the unit – whose brands include Sensodyne toothpaste and Voltaren and Panadol painkillers and Centrum multivitamins ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...

Now that its hand has been revealed, there is no question that Unilever will do its best to acquire the consumer division of GlaxoSmithKline as it completes its demerger. Its £50bn offer may rise ...

Twelve months on from the first lockdowns in the west, brands and media are taking stock of the past year and making decisions on where to go next. Looking back, Tamara Rogers, global CMO at GSK ...

GSK plc GSK announced that the FDA has approved ... A commercial launch for the drug is planned in second-half 2025 under the brand name Blujepa. This approval for Blujepa marks the introduction ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group.As part of the transaction, Haleon, known for household brands ...